BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21632805)

  • 1. Rare metastases of differentiated thyroid carcinoma: pictorial review.
    Song HJ; Xue YL; Xu YH; Qiu ZL; Luo QY
    Endocr Relat Cancer; 2011 Oct; 18(5):R165-74. PubMed ID: 21632805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPECT/CT and I131 therapy of brain metastases from follicular variant papillary thyroid carcinoma (FVPTC).
    Olson AC; Haugen BR; Walter J; Kwak JJ; Bagrosky BM; Koo PJ
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3511-2. PubMed ID: 25057877
    [No Abstract]   [Full Text] [Related]  

  • 3. Uncommon metastases from differentiated thyroid carcinoma.
    Song HJ; Xue YL; Qiu ZL; Luo QY
    Hell J Nucl Med; 2012; 15(3):233-40. PubMed ID: 23106056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual intratracheal metastasis of differentiated thyroid cancer accurately depicted by SPECT/CT acquisition after radioiodine ablation.
    Aide N; Lehembre E; Gervais R; Bardet S
    Thyroid; 2007 Dec; 17(12):1305-6. PubMed ID: 17949266
    [No Abstract]   [Full Text] [Related]  

  • 6. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
    Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
    J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer.
    Wang H; Fu HL; Li JN; Zou RJ; Gu ZH; Wu JC
    Clin Imaging; 2009; 33(1):49-54. PubMed ID: 19135930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
    Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
    J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases.
    Mihailovic J; Stefanovic L; Malesevic M; Markoski B
    Thyroid; 2009 Mar; 19(3):227-32. PubMed ID: 19265493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization and identification of parapharyngeal metastases from differentiated thyroid carcinoma by 131I-SPECT/CT.
    Qiu ZL; Xu YH; Song HJ; Luo QY
    Head Neck; 2011 Feb; 33(2):171-7. PubMed ID: 20848436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erector spinae metastases from differentiated thyroid cancer identified by I-131 SPECT/CT.
    Qiu ZL; Luo QY
    Clin Nucl Med; 2009 Mar; 34(3):137-40. PubMed ID: 19352273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
    Wong KK; Sisson JC; Koral KF; Frey KA; Avram AM
    AJR Am J Roentgenol; 2010 Sep; 195(3):730-6. PubMed ID: 20729453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer.
    Aide N; Heutte N; Rame JP; Rousseau E; Loiseau C; Henry-Amar M; Bardet S
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2075-84. PubMed ID: 19276233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of (99m)Tc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients.
    Chantadisai M; Kingpetch K
    Ann Nucl Med; 2014 Aug; 28(7):674-82. PubMed ID: 24889127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual Sites of Metastatic and Benign I 131 Uptake in Patients with Differentiated Thyroid Carcinoma.
    Palaniswamy SS; Subramanyam P
    Indian J Endocrinol Metab; 2018; 22(6):740-750. PubMed ID: 30766811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroperative detection with a gamma probe of pelvic metastasis after differentiated thyroid carcinoma in female patients: about two cases and management reflections.
    Pirvu A; Guigard S; Blaise H; Chaffanjon P
    Chirurgia (Bucur); 2013; 108(1):126-9. PubMed ID: 23464784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.
    Yamamoto Y; Nishiyama Y; Monden T; Matsumura Y; Satoh K; Ohkawa M
    J Nucl Med; 2003 Dec; 44(12):1905-10. PubMed ID: 14660715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.
    Qiu ZL; Shen CT; Luo QY
    Thyroid; 2015 Feb; 25(2):229-37. PubMed ID: 25331724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging?
    Avram AM; Fig LM; Frey KA; Gross MD; Wong KK
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1163-71. PubMed ID: 23430789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy analysis of (131)I therapy and predictive value of preablation stimulated thyroglobulin for lung metastases from differentiated thyroid cancer.
    Wu S; Wang H
    Ann Endocrinol (Paris); 2013 Feb; 74(1):40-4. PubMed ID: 23337017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.